loader2
Partner With Us NRI

Amrutanjan Health Care Ltd share Price

Company details

585.00
596.00
554.05
847.25
6M Return -16.66%
1Y Return -27.21%
Mkt Cap.(Cr) 1,715.71
Volume 33,477
Div Yield 0.61%
OI
-
OI Chg %
-
Volume 33,477

Open Free Trading Account Online with ICICIDIRECT

Amrutanjan Health Care Ltd.

Q1FY23 Quarterly Result Announced for Amrutanjan Health Care Ltd.

Pharmaceuticals firm Amrutanjan Health Care announced Q1FY23 Result :

  • Key raw material prices excluding Menthol crystal price are higher when compared to Q1 FY22.
  • The prices of packing materials are higher when compared to Q1 FY22.
  • Advertisement spend for Q1 FY23 is at Rs.5.20 cr against Rs.4.28 cr for Q1 FY22. Advertisement spend for Comfy is at 3.90 cr for Q1 FY23 against 3.31 cr for Q1 FY22.

 

Result PDF

View Other Company Results

FINANCIALS

Sales
Operating Profit
Profit after Tax
Equity
Reserves and Surplus
Debt
Sales
Operating Profit
Profit after Tax
PE
Debt/Equity
P BV

Amrutanjan Health Care Ltd Stocks COMPARISION

INSIDER & INSTITUIONAL ACTIVITY

Equity Capital: 265.12 Cr FV: 1.00

Period MF Net Purchase / (sold) FII Net
LAST 1M 6,453.77 33,147.37
LAST 3M 17,843.41 60,442.99
LAST 6M 65,045.76 45,150.76
LAST 12M 117,698.99 96,636.68

Amrutanjan Health Care Ltd Information

Stock PE (TTM)
43.19
Promoter Holding
50.04%
Book Value
99.4755
ROCE
36.78%
ROE
27.96%
Description
  • The Madras-based Amrutanjan manufactures bulk drugs and drug intermediateslike theophylline, based on in-house research. Three plants have been set up in the Alandur industrial belt near Madras to produce these products. It recently entered into a joint venture with Welsh firm Cardiff Chemicals to manufacture pheromones (a type of agrochemicals) at Cuddalore. Pheromones have found wide application as pesticides and are used on cotton crops. Amrutanjan also has an agreement with a company in Philadelphia, US, to supply custom-made chemicals for exotic applications like the genetic manipulation of biological matter. It has introduced some new range of products like Pep Pill, Amrutanjan gripe water sans alcohol, Amrutanjan Maha Strong, etc. Plans are afoot to introduce analgesic and antipyretic tablets. The company also plans to launch sanitary napkins soon. The company has approached the US FDA for approval and clearance to sell its new drugs in US. During 1996-97, it has introduced a new product called `Cold Snap Gel` and also a mint called `tingle`. Company having two subsidiary companies viz. Amrutanjan Drugs & Chemicals Ltd having holding stake 99.80% & Amrutanjan Finance Ltd, having holding stake is 57.26%. Company has taken efforts to increase the export of fine chemicals & also taking major efforts to give full thrust to existing products. Amrutanjan also modernising its OTC business and expanding its export of fine chemicals which reflects to turnover & net Profit of the Company. `Diakyur` for the treatment of Diabetes was introduced during 2000-2001 and it has been well accepted by the customers. The company`s R & D has been engaged in the development of neutraceuticals.The company is mainly focussing on Bio-Tech products and expects a good results from this division. During 2001-02 the company allotted 16,00,000 equity bonus shares of Rs.10/- each and subsequently the share capital has increased from Rs.1.60 crores to Rs.3.20 crores.

Registered Address

New 103 Old 42-45 LuzChurch Rd, Mylapore, Chennai, Tamil Nadu, 600004

Tel : 91-44-24994164/24994465/24994366
Email : shares:amrutanjan.com
Website : http://www.amrutanjan.com
Registrar

Cameo Corporate Services Ltd

AGM Date (Month) : Sep
Face Value Equity Shares : 1
Market Lot Equity Shares : 1
BSE Code : 590006
NSE Code : AMRUTANJAN
Book Closure Date (Month) : Sep
BSE Group : B
ISIN : INE098F01031

FAQ’s on Amrutanjan Health Care Ltd Shares

You can buy Amrutanjan Health Care Ltd shares through a brokerage firm. ICICIdirect is a registered broker through which you can place orders to buy Amrutanjan Health Care Ltd Share.

Company share prices and volatile and keep changing according to the market conditions. As of Jun 08, 2023 03:49 PM the closing price of Amrutanjan Health Care Ltd was ₹ 586.95.

Market capitalization or market cap is determined by multiplying the current market price of a company’s shares with the total number of shares outstanding. As of Jun 08, 2023 03:49 PM, the market cap of Amrutanjan Health Care Ltd stood at ₹ 1,715.71.

The latest PE ratio of Amrutanjan Health Care Ltd as of Jun 08, 2023 03:49 PM is 43.19

The latest PB ratio of Amrutanjan Health Care Ltd as of Jun 08, 2023 03:49 PM is 0.17

The 52-week high of Amrutanjan Health Care Ltd is ₹ 847.25 while the 52-week low is ₹ 554.05

Download Our App

market app
market app